Maternal thyroid cancer. ARC Journal of Cancer Science 4(1), 1-4.

What is it about?

The normal cooperation in the maternal hypothalamic-pituitary-thyroid axis (HPTA) during pregnancy is critical for the fetal and neonatal development. The maternal thyroid cancer may delay the actions of all central biological systems during the prenatal and postnatal periods. Also, the treatment may be vital to inhibit the development of thyroid cancer. This can keep the stability in the HPTA during the perinatal period. All efforts should be accomplished to avoid the exposure to radiation and to find thyroid tumors carefully during pregnancy and lactation periods. Further studies are needed to discover the diagnostic and prognostic markers, and to design novel drugs for the common endocrine malignancy in particular the thyroid cancer. In addition, the molecular actions controlling the immune-cytokine networks as well as lymphangiogenesis/angiogenesis in several types of thyroid cancer should be examined. These problems need more analysis.

Featured Image

Why is it important?

The maternal thyroid cancer may delay the actions of all central biological systems during the prenatal and postnatal periods. Also, the treatment may be vital to inhibit the development of thyroid cancer.Also, the treatment may be vital to inhibit the development of thyroid cancer. This can keep the stability in the HPTA during the perinatal period. All efforts should be accomplished to avoid the exposure to radiation and to find thyroid tumors carefully during pregnancy and lactation periods.

Perspectives